Skip to main navigation Skip to search Skip to main content

Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli

Research output: Contribution to journalArticleResearchpeer-review

Abstract

We described bacterial killing and resistance emergence at various fixed concentrations of meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli. Time-kill studies were conducted utilizing nine isolates and a large range of concentrations. Within each strain and antibiotic, initial killing was similar, with concentrations ≥2×MIC. At many (strain-specific) concentrations causing substantial initial killing, regrowth occurred at 24-48h. For remaining concentrations, growth typically remained suppressed (<5-log10 cfu/mL). The concentrations of meropenem required to suppress regrowth ranged from 2–8×MIC for P. aeruginosa and 2–64×MIC for E. coli. For piperacillin/tazobactam, the equivalent concentrations ranged from 8–16×MIC for P. aeruginosa and 4–16×MIC for E. coli. The number of less-susceptible bacteria increased with rising concentrations before decreasing at even higher concentrations. Suppression of regrowth and resistance was substantially improved with higher concentrations (typically ≥8×MIC), suggesting a benefit of higher β-lactam concentrations beyond those required for maximum initial killing.

Original languageEnglish
Pages (from-to)69-76
Number of pages8
JournalDiagnostic Microbiology and Infectious Disease
Volume91
Issue number1
DOIs
Publication statusPublished - 1 May 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Bacterial killing
  • beta-Lactam antibiotics
  • In vitro studies
  • Resistance

Cite this